Earnings Outlook For Protalix BioTherapeutics
Earnings Outlook For Protalix BioTherapeutics
It's worth noting for new investors that guidance can be a key determinant of stock price movements.Protalix BioTherapeutics (AMEX:PLX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.
protalix biotherapeutics (美交所:PLX) 正在準備於2024年11月14日週四公佈其季度業績。以下是投資者在發佈前需要知道的簡要概述。
Analysts are estimating that Protalix BioTherapeutics will report an earnings per share (EPS) of $0.04.
分析師預計protalix biotherapeutics將報告每股收益（EPS）爲0.04美元。
The announcement from Protalix BioTherapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
投資者迫切期待protalix biotherapeutics的公告，希望能夠超出預期的資訊以及對下個季度的良好指引。
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
值得注意的是，對於新投資者來說，指導可能是股票價格波動的關鍵因素。
Performance in Previous Earnings
Performance in Previous Earnings
In the previous earnings release, the company missed EPS by $0.05, leading to a 2.15% increase in the share price the following trading session.
在之前的業績發佈中，該公司每股收益低於預期0.05美元，導致下一個交易日股價上漲2.15%。
Here's a look at Protalix BioTherapeutics's past performance and the resulting price change:
以下是protalix biotherapeutics過去的表現及其帶來的價格變化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.02 | -0.02 | -0.03 | -0.04 |
| EPS Actual | -0.03 | -0.06 | -0.07 | -0.04 |
| Price Change % | 2.0% | -12.0% | -3.0% | -1.0% |
| 季度 | 2024年第二季度 | 2024年第一季度 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| 每股收益預估值 | 0.02 | -0.02 | -0.03 | -0.04 |
| 每股收益實際值 | -0.03 | -0.06 | -0.07 | -0.04 |
| 價格變更% | 2.0% | -12.0% | -3.0% | -1.0% |
Stock Performance
股票表現
Shares of Protalix BioTherapeutics were trading at $1.32 as of November 12. Over the last 52-week period, shares are down 9.71%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
截至11月12日，protalix biotherapeutics的股票交易價格爲1.32美元。在過去的52周裏，股票下跌了9.71%。由於這些回報一般都是負的，長期股東在進入這次業績發佈時可能會有些不滿。
To track all earnings releases for Protalix BioTherapeutics visit their earnings calendar on our site.
要查看protalix biotherapeutics的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
